Appendicitis Medication
- Author: Sandy Craig, MD; Chief Editor: Barry E Brenner, MD, PhD, FACEP more...
Medication Summary
The goals of therapy are to eradicate the infection and to prevent complications. Thus, antibiotics have an important role in the treatment of appendicitis, and all such. Agents under consideration must offer full aerobic and anaerobic coverage. The duration of the administration is closely related to the stage of appendicitis at the time of the diagnosis.
Antibiotic agents are effective in decreasing the rate of postoperative wound infection and in improving outcome in patients with appendiceal abscess or septicemia. The Surgical Infection Society recommends starting prophylactic antibiotics before surgery, using appropriate spectrum agents for less than 24 hours for nonperforated appendicitis and for less than 5 days for perforated appendicitis. Regimens are of approximately equal efficacy, so consideration should be given to features such as medication allergy, pregnancy category (if applicable), toxicity, and cost.
Penicillins
Class Summary
The penicillins are bactericidal antibiotics that work against sensitive organisms at adequate concentrations and inhibit the biosynthesis of cell wall mucopeptide.
Piperacillin and tazobactam sodium (Zosyn)
This agent is a drug combination of beta-lactamase inhibitor with piperacillin. It has activity against some gram-positive organisms, gram-negative organisms, and anaerobic bacteria. When used as a single agent, it inhibits biosynthesis of cell wall mucopeptide and is effective during active multiplication stages.
Ampicillin and sulbactam (Unasyn)
This agent is a drug combination of beta-lactamase inhibitor with ampicillin. It is used as a single agent and interferes with bacterial cell wall synthesis during active replication, causing bactericidal activity against susceptible organisms. Ampicillin/sulbactam also has activity against some gram-positive organisms, gram-negative organisms (nonpseudomonal species), and anaerobic bacteria.
Ticarcillin/clavulanate (Timentin)
Ticarcillin/clavulanate inhibits biosynthesis of cell wall mucopeptide and is effective during the stage of active growth. It is an antipseudomonal penicillin plus beta-lactamase inhibitor that provides coverage against most gram-positive organisms, most gram-negative organisms, and most anaerobic organisms.
Cephalosporins
Class Summary
Cephalosporins are structurally and pharmacologically related to penicillins. They inhibit bacterial cell wall synthesis, resulting in bactericidal activity.
Cefotetan (Cefotan)
Cefotetan is a second-generation cephalosporin that is used as single-drug therapy for broad gram-negative and anaerobic coverage. Administer cefotetan with cefoxitin to achieve the effectiveness of single dose. Its half-life is 3.5 hours.
Cefoxitin (Mefoxin)
This drug is also a second-generation cephalosporin that is indicated as single agent for the management of infections caused by susceptible gram-positive cocci and gram-negative rods. It has a half-life of 0.8 hours.
Cefepime
Cefepime is a fourth-generation cephalosporin. It has gram-negative coverage comparable to ceftazidime but has better gram-positive coverage. Cefepime is a zwitter ion that rapidly penetrates gram-negative cells.
Aminoglycosides
Class Summary
Aminoglycosides have concentration-dependent bactericidal activity. These agents work by binding to the 30S ribosome, inhibiting bacterial protein synthesis.
Gentamicin (Gentacidin, Garamycin)
Gentamicin is an aminoglycoside antibiotic used for gram-negative coverage, as well as in combination with an agent against gram-positive organisms and another one against anaerobes. Gentamicin is not the drug of choice, but consider using this drug if penicillins or other less toxic drugs are contraindicated, when it is clinically indicated, and in mixed infections caused by susceptible staphylococci and gram-negative organisms. This agent may be administered intravenously or intramuscularly and has numerous regimens; the dose must be adjusted for creatinine clearance and changes in volume of distribution.
Carbapenems
Class Summary
Carbapenems are structurally related to penicillins and have broad-spectrum bactericidal activity. The carbapenems exert their effect by inhibiting cell wall synthesis, which leads to cell death. They are active against gram-negative, gram-positive, and anaerobic organisms.
Meropenem (Merrem)
Meropenem is a bactericidal broad-spectrum carbapenem antibiotic that inhibits cell wall synthesis. It is used as a single agent and is effective against most gram-positive and gram-negative bacteria.
Ertapenem
Ertapenem has bactericidal activity that results from the inhibition of cell wall synthesis and is mediated through ertapenem binding to penicillin-binding proteins. It is stable against hydrolysis by a variety of beta-lactamases, including penicillinase, cephalosporinase, and extended-spectrum beta-lactamases.
Fluoroquinolones
Class Summary
These agents can be used to relieve acute undifferentiated abdominal pain in patients presenting to the ED.
Ciprofloxacin (Cipro)
Ciprofloxacin is a fluoroquinolone that inhibits bacterial DNA synthesis and, consequently, growth, by inhibiting DNA gyrase and topoisomerase, which are required for replication, transcription, and translation of genetic material. Quinolones have broad activity against gram-positive and gram-negative aerobic organisms.
Levofloxacin (Levaquin)
Levofloxacin is used for infections caused by various gram-negative organisms, antipseudomonal infections due to multidrug resistant gram-negative organisms.
Moxifloxacin (Avelox)
Moxifloxacin is a fluoroquinolone that inhibits A subunits of DNA gyrase, inhibiting bacterial DNA replication and transcription.
Anti-infective Agents
Class Summary
Anti-infectives such as metronidazole and tigecycline are effective against many types of bacteria that have become resistant to other antibiotics.
Metronidazole (Flagyl)
Metronidazole has broad gram-negative and anaerobic coverage and is used in combination with aminoglycosides (eg, gentamicin). This agent appears to be absorbed into cells; intermediate metabolized compounds bind DNA and inhibit protein synthesis, causing cell death.
Tigecycline (Tygacil)
Tigecycline is a glycylcycline antibiotic that is structurally similar to tetracycline antibiotics. It inhibits bacterial protein translation by binding to the 30S ribosomal subunit, and it blocks entry of amino-acyl tRNA molecules into the ribosome A site.
Analgesics
Class Summary
These agents can be used to relieve acute undifferentiated abdominal pain in patients presenting to the ED.
Morphine sulfate (Astramorph, Duramorph, MS Contin, MSIR, Oramorph)
Morphine sulfate is the drug of choice for analgesia because of its reliable and predictable effects, safety profile, and ease of reversibility with naloxone. Various intravenous doses are used; morphine sulfate is commonly titrated to the desired effect.
Karamanakos SN, Sdralis E, Panagiotopoulos S, Kehagias I. Laparoscopy in the emergency setting: a retrospective review of 540 patients with acute abdominal pain. Surg Laparosc Endosc Percutan Tech. Apr 2010;20(2):119-24. [Medline].
Niwa H, Hiramatsu T. A rare presentation of appendiceal diverticulitis associated with pelvic pseudocyst. World J Gastroenterol. Feb 28 2008;14(8):1293-5. [Medline]. [Full Text].
Yeh B. Evidence-based emergency medicine/rational clinical examination abstract. Does this adult patient have appendicitis?. Ann Emerg Med. Sep 2008;52(3):301-3. [Medline].
Place RC. Acute urinary retention in a 9-year-old child: an atypical presentation of acute appendicitis. J Emerg Med. Aug 2006;31(2):173-5. [Medline].
Oto A, Ernst RD, Mileski WJ, Nishino TK, Le O, Wolfe GC, et al. Localization of appendix with MDCT and influence of findings on choice of appendectomy incision. AJR Am J Roentgenol. Oct 2006;187(4):987-90. [Medline].
Howell JM, Eddy OL, Lukens TW, Thiessen ME, Weingart SD, Decker WW. Clinical policy: Critical issues in the evaluation and management of emergency department patients with suspected appendicitis. Ann Emerg Med. Jan 2010;55(1):71-116. [Medline].
National Guideline Clearinghouse (NGC). Guideline summary: Clinical policy: critical issues in the evaluation and management of emergency department patients with suspected appendicitis. National Guideline Clearinghouse (NGC), Rockville (MD). Available at http://www.guideline.gov. Accessed 2011 Feb 24.
Markle GB 4th. Heel-drop jarring test for appendicitis. Arch Surg. Feb 1985;120(2):243. [Medline].
Sedlak M, Wagner OJ, Wild B, Papagrigoriades S, Exadaktylos AK. Is there still a role for rectal examination in suspected appendicitis in adults?. Am J Emerg Med. Mar 2008;26(3):359-60. [Medline].
Alvarado A. A practical score for the early diagnosis of acute appendicitis. Ann Emerg Med. May 1986;15(5):557-64. [Medline].
[Best Evidence] Schneider C, Kharbanda A, Bachur R. Evaluating appendicitis scoring systems using a prospective pediatric cohort. Ann Emerg Med. Jun 2007;49(6):778-84, 784.e1. [Medline].
Schneider C, Kharbanda A, Bachur R. Evaluating appendicitis scoring systems using a prospective pediatric cohort. Ann Emerg Med. Jun 2007;49(6):778-84, 784.e1. [Medline].
Migraine S, Atri M, Bret PM, Lough JO, Hinchey JE. Spontaneously resolving acute appendicitis: clinical and sonographic documentation. Radiology. Oct 1997;205(1):55-8. [Medline].
Cobben LP, de Van Otterloo AM, Puylaert JB. Spontaneously resolving appendicitis: frequency and natural history in 60 patients. Radiology. May 2000;215(2):349-52. [Medline].
Dueholm S, Bagi P, Bud M. Laboratory aid in the diagnosis of acute appendicitis. A blinded, prospective trial concerning diagnostic value of leukocyte count, neutrophil differential count, and C-reactive protein. Dis Colon Rectum. Oct 1989;32(10):855-9. [Medline].
Thimsen DA, Tong GK, Gruenberg JC. Prospective evaluation of C-reactive protein in patients suspected to have acute appendicitis. Am Surg. Jul 1989;55(7):466-8. [Medline].
de Carvalho BR, Diogo-Filho A, Fernandes C, Barra CB. [Leukocyte count, C reactive protein, alpha-1 acid glycoprotein and erythrocyte sedimentation rate in acute appendicitis]. Arq Gastroenterol. Jan-Mar 2003;40(1):25-30. [Medline].
Albu E, Miller BM, Choi Y, et al. Diagnostic value of C-reactive protein in acute appendicitis. Dis Colon Rectum. Jan 1994;37(1):49-51. [Medline].
Gurleyik E, Gurleyik G, Unalmiser S. Accuracy of serum C-reactive protein measurements in diagnosis of acute appendicitis compared with surgeon's clinical impression. Dis Colon Rectum. Dec 1995;38(12):1270-4. [Medline].
Shakhatreh HS. The accuracy of C-reactive protein in the diagnosis of acute appendicitis compared with that of clinical diagnosis. Med Arh. 2000;54(2):109-10. [Medline].
Asfar S, Safar H, Khoursheed M, Dashti H, al-Bader A. Would measurement of C-reactive protein reduce the rate of negative exploration for acute appendicitis?. J R Coll Surg Edinb. Feb 2000;45(1):21-4. [Medline].
Erkasap S, Ates E, Ustuner Z, Sahin A, Yilmaz S, Yasar B, et al. Diagnostic value of interleukin-6 and C-reactive protein in acute appendicitis. Swiss Surg. 2000;6(4):169-72. [Medline].
Gronroos JM, Gronroos P. Leucocyte count and C-reactive protein in the diagnosis of acute appendicitis. Br J Surg. Apr 1999;86(4):501-4. [Medline].
Ortega-Deballon P, Ruiz de Adana-Belbel JC, Hernandez-Matias A, Garcia-Septiem J, Moreno-Azcoita M. Usefulness of laboratory data in the management of right iliac fossa pain in adults. Dis Colon Rectum. Jul 2008;51(7):1093-9. [Medline].
Gronroos JM. Is there a role for leukocyte and CRP measurements in the diagnosis of acute appendicitis in the elderly?. Maturitas. Mar 15 1999;31(3):255-8. [Medline].
Yang HR, Wang YC, Chung PK, et al. Role of leukocyte count, neutrophil percentage, and C-reactive protein in the diagnosis of acute appendicitis in the elderly. Am Surg. Apr 2005;71(4):344-7. [Medline].
Gronroos JM. Do normal leucocyte count and C-reactive protein value exclude acute appendicitis in children?. Acta Paediatr. Jun 2001;90(6):649-51. [Medline].
Stefanutti G, Ghirardo V, Gamba P. Inflammatory markers for acute appendicitis in children: are they helpful?. J Pediatr Surg. May 2007;42(5):773-6. [Medline].
Mohammed AA, Daghman NA, Aboud SM, Oshibi HO. The diagnostic value of C-reactive protein, white blood cell count and neutrophil percentage in childhood appendicitis. Saudi Med J. Sep 2004;25(9):1212-5. [Medline].
Yang HR, Wang YC, Chung PK, Chen WK, Jeng LB, Chen RJ. Laboratory tests in patients with acute appendicitis. ANZ J Surg. Jan-Feb 2006;76(1-2):71-4. [Medline].
Tundidor Bermudez AM, Amado Dieguez JA, Montes de Oca Mastrapa JL. [Urological manifestations of acute appendicitis]. Arch Esp Urol. Apr 2005;58(3):207-12. [Medline].
Bolandparvaz S, Vasei M, Owji AA, Ata-Ee N, Amin A, Daneshbod Y, et al. Urinary 5-hydroxy indole acetic acid as a test for early diagnosis of acute appendicitis. Clin Biochem. Nov 2004;37(11):985-9. [Medline].
Rao PM, Rhea JT, Rattner DW, et al. Introduction of appendiceal CT: impact on negative appendectomy and appendiceal perforation rates. Ann Surg. Mar 1999;229(3):344-9. [Medline].
McGory ML, Zingmond DS, Nanayakkara D, Maggard MA, Ko CY. Negative appendectomy rate: influence of CT scans. Am Surg. Oct 2005;71(10):803-8. [Medline].
Harswick C, Uyenishi AA, Kordick MF, Chan SB. Clinical guidelines, computed tomography scan, and negative appendectomies: a case series. Am J Emerg Med. Jan 2006;24(1):68-72. [Medline].
Frei SP, Bond WF, Bazuro RK, Richardson DM, Sierzega GM, Reed JF. Appendicitis outcomes with increasing computed tomographic scanning. Am J Emerg Med. Jan 2008;26(1):39-44. [Medline].
Pickhardt PJ, Lawrence EM, Pooler BD, Bruce RJ. Diagnostic performance of multidetector computed tomography for suspected acute appendicitis. Ann Intern Med. Jun 21 2011;154(12):789-96. [Medline].
Kim K, Kim YH, Kim SY, Kim S, Lee YJ, Kim KP, et al. Low-dose abdominal CT for evaluating suspected appendicitis. N Engl J Med. Apr 26 2012;366(17):1596-605. [Medline].
Brenner DJ, Hall EJ. Computed tomography--an increasing source of radiation exposure. N Engl J Med. Nov 29 2007;357(22):2277-84. [Medline].
Zilbert NR, Stamell EF, Ezon I, Schlager A, Ginsburg HB, Nadler EP. Management and outcomes for children with acute appendicitis differ by hospital type: areas for improvement at public hospitals. Clin Pediatr (Phila). Jun 2009;48(5):499-504. [Medline].
[Best Evidence] Doria AS, Moineddin R, Kellenberger CJ, Epelman M, Beyene J, Schuh S, et al. US or CT for Diagnosis of Appendicitis in Children and Adults? A Meta-Analysis. Radiology. Oct 2006;241(1):83-94. [Medline].
Barloon TJ, Brown BP, Abu-Yousef MM, Warnock N, Berbaum KS. Sonography of acute appendicitis in pregnancy. Abdom Imaging. Mar-Apr 1995;20(2):149-51. [Medline].
Cobben LP, Groot I, Haans L, Blickman JG, Puylaert J. MRI for clinically suspected appendicitis during pregnancy. AJR Am J Roentgenol. Sep 2004;183(3):671-5. [Medline].
Manterola C, Vial M, Moraga J, Astudillo P. Analgesia in patients with acute abdominal pain. Cochrane Database Syst Rev. Jan 19 2011;1:CD005660. [Medline].
Eriksson S, Granström L. Randomized controlled trial of appendicectomy versus antibiotic therapy for acute appendicitis. Br J Surg. Feb 1995;82(2):166-9. [Medline].
Bickell NA, Aufses AH Jr, Rojas M, Bodian C. How time affects the risk of rupture in appendicitis. J Am Coll Surg. Mar 2006;202(3):401-6. [Medline].
Abou-Nukta F, Bakhos C, Arroyo K, Koo Y, Martin J, Reinhold R, et al. Effects of delaying appendectomy for acute appendicitis for 12 to 24 hours. Arch Surg. May 2006;141(5):504-6; discussion 506-7. [Medline].
[Guideline] Korndorffer JR Jr, Fellinger E, Reed W. SAGES guideline for laparoscopic appendectomy. Surg Endosc. Apr 2010;24(4):757-61. [Medline]. [Full Text].
Liang MK, Lo HG, Marks JL. Stump appendicitis: a comprehensive review of literature. Am Surg. Feb 2006;72(2):162-6. [Medline].
| Characteristic | Score |
| M = Migration of pain to the RLQ | 1 |
| A = Anorexia | 1 |
| N = Nausea and vomiting | 1 |
| T = Tenderness in RLQ | 2 |
| R = Rebound pain | 1 |
| E = Elevated temperature | 1 |
| L = Leukocytosis | 2 |
| S = Shift of WBCs to the left | 1 |
| Total | 10 |
| Source: Alvarado.[10] | |
| RLQ = right lower quadrant; WBCs = white blood cells | |
| WBC (× 10,000) | Likelihood Ratio (95% CI) |
| 4-7 | 0.10 (0-0.39) |
| 7-9 | 0.52 (0-1.57) |
| 9-11 | 0.29 (0-0.62) |
| 11-13 | 2.8 (1.2-4.4) |
| 13-15 | 1.7 (0-3.6) |
| 15-17 | 2.8 (0-6.0) |
| 17-19 | 3.5 (0-10) |
| 19-22 | ∞ |
| Source: Dueholm et al.[15] | |
| CI = confidence interval; WBC = white blood cell. | |

